US Patent Issued to Encoded Therapeutics on July 28 for "Tissue selective transgene expression" (California Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,516, issued on July 28, was assigned to Encoded Therapeutics Inc. (South San Francisco, Calif.).

"Tissue selective transgene expression" was invented by Stephanie Tagliatela (South San Francisco, Calif.), Andrew Young (Redwood City, Calif.), Szu-Ying Chen (South San Francisco, Calif.), Kartik Ramamoorthi (South San Francisco, Calif.) and David Oberkofler (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions and methods for selective expression of a transgene. Compositions and methods for selective expression of a transgene comprise one or more human regulatory elements, which, when operably link...